PharmaCielo Ltd. (TSXV:PCLO)
Canada flag Canada · Delayed Price · Currency is CAD
0.0600
0.00 (0.00%)
Aug 28, 2026, 12:01 PM EST

PharmaCielo Cash Flow Statement

Millions CAD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Dec '24 Dec '23 Dec '22
Net Income
-3.71-3.58-9.1-9.14-16.3-14.52
Depreciation & Amortization
1.31.41.310.141.410.43
Loss (Gain) From Sale of Assets
-2.29-2.240.02-0-0.04
Asset Writedown & Restructuring Costs
--0.660.914.231.27
Loss (Gain) From Sale of Investments
--0.19--0.030.14
Loss (Gain) on Equity Investments
-----0.64
Stock-Based Compensation
0.050.110.911.041.542.21
Provision & Write-off of Bad Debts
----0.020
Other Operating Activities
1.681.493.474.291.741.78
Change in Accounts Receivable
0.110.19-0.19-0.130.42-0.4
Change in Inventory
-0.53-0.790.390.390.75-1.01
Change in Accounts Payable
-3.61-0.570.50.280.67-0.35
Change in Other Net Operating Assets
0.03-0.650.160.260.38-0.03
Operating Cash Flow
-6.96-4.61-1.69-1.97-5.15-9.88
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-----0.02-0.52
Sale of Property, Plant & Equipment
10.0510.01----
Investment in Securities
----0.18-0.2
Other Investing Activities
--0.030.040.230.17
Investing Cash Flow
10.0510.010.030.040.39-0.56

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Dec '24 Dec '23 Dec '22
Short-Term Debt Issued
-0.42----
Long-Term Debt Issued
---0.995.455.8
Total Debt Issued
0.530.422.390.995.455.8
Long-Term Debt Repaid
--5.85--0.52-0.82-0.62
Total Debt Repaid
-3.57-5.85-0.74-0.52-0.82-0.62
Net Debt Issued (Repaid)
-3.04-5.441.650.474.635.17
Issuance of Common Stock
---1.55-0.08
Other Financing Activities
-----0.04
Financing Cash Flow
-3.04-5.441.652.024.635.3

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Dec '24 Dec '23 Dec '22
Foreign Exchange Rate Adjustments
0.0200-0.010.02-0.03
Net Cash Flow
0.07-0.04-0.010.09-0.11-5.17

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-6.96-4.61-1.69-1.97-5.17-10.4
Free Cash Flow Growth
------
Free Cash Flow Margin
-193.01%-181.86%-53.10%-56.59%-335.01%-195.86%
Free Cash Flow Per Share
-0.04-0.02-0.01-0.01-0.03-0.07
Levered Free Cash Flow
-5.71-3.55--2.45-5.02-7.5
Unlevered Free Cash Flow
-4.21-2.05--1.03-3.33-6.54

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Dec '24 Dec '23 Dec '22
Cash Interest Paid
---1.23--
Change in Working Capital
-3.99-1.810.860.792.22-1.79